Patrick M. Abou‐Sleiman

8.6k total citations · 2 hit papers
36 papers, 3.7k citations indexed

About

Patrick M. Abou‐Sleiman is a scholar working on Neurology, Neurology and Molecular Biology. According to data from OpenAlex, Patrick M. Abou‐Sleiman has authored 36 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 11 papers in Neurology and 10 papers in Molecular Biology. Recurrent topics in Patrick M. Abou‐Sleiman's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological diseases and metabolism (10 papers) and Nuclear Receptors and Signaling (8 papers). Patrick M. Abou‐Sleiman is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological diseases and metabolism (10 papers) and Nuclear Receptors and Signaling (8 papers). Patrick M. Abou‐Sleiman collaborates with scholars based in United Kingdom, United States and Netherlands. Patrick M. Abou‐Sleiman's co-authors include Nicholas Wood, Miratul M. K. Muqit, Daniel G. Healy, Andrew J. Lees, Niall Quinn, Sonia Gandhi, Kailash P. Bhatia, Janice L. Holton, Tamás Révész and William P. Gilks and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature reviews. Neuroscience.

In The Last Decade

Patrick M. Abou‐Sleiman

36 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expanding insights of mitochondrial dysfunction in Parkinson's disease

2006 703 citations Patrick M. Abou‐Sleiman, Miratul M. K. Muqit et al. profile →
A common LRRK2 mutation in idiopathic Parkinson's disease

2005 575 citations Patrick M. Abou‐Sleiman, Sonia Gandhi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick M. Abou‐Sleiman United Kingdom	23	2.2k	1.4k	1.2k	733	681	36	3.7k
Janet Hoenicka Spain	26	2.2k 1.0×	868 0.6×	1.6k 1.3×	967 1.3×	486 0.7×	76	3.8k
Wilma D. J. van de Berg Netherlands	39	2.3k 1.0×	1.0k 0.8×	1.1k 0.9×	1.4k 1.9×	897 1.3×	130	4.5k
Pierre‐Olivier Fernagut France	39	3.0k 1.4×	1.2k 0.9×	2.4k 1.9×	815 1.1×	909 1.3×	90	5.1k
Kunimasa Arima Japan	38	1.5k 0.7×	1.3k 1.0×	959 0.8×	1.3k 1.8×	1.0k 1.5×	100	4.3k
John F. Crary United States	31	1.1k 0.5×	1.7k 1.2×	1.1k 0.9×	1.2k 1.7×	553 0.8×	111	4.1k
Jochen H. Weishaupt Germany	48	3.2k 1.5×	3.0k 2.2×	1.8k 1.5×	1.2k 1.7×	1.4k 2.1×	146	6.9k
Sheng‐Han Kuo United States	37	2.6k 1.2×	1.6k 1.2×	2.3k 1.9×	828 1.1×	653 1.0×	163	5.4k
Imke Puls Germany	22	1.3k 0.6×	1.4k 1.0×	1.3k 1.0×	307 0.4×	523 0.8×	40	3.8k
Evelyn Jaros United Kingdom	40	2.2k 1.0×	2.6k 1.9×	1.4k 1.1×	1.7k 2.3×	901 1.3×	77	5.8k
Norbert Brüggemann Germany	31	2.1k 1.0×	802 0.6×	1.1k 0.9×	400 0.5×	540 0.8×	192	3.3k

Countries citing papers authored by Patrick M. Abou‐Sleiman

Since Specialization

Citations

This map shows the geographic impact of Patrick M. Abou‐Sleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Abou‐Sleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Abou‐Sleiman more than expected).

Fields of papers citing papers by Patrick M. Abou‐Sleiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick M. Abou‐Sleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Abou‐Sleiman. The network helps show where Patrick M. Abou‐Sleiman may publish in the future.

Co-authorship network of co-authors of Patrick M. Abou‐Sleiman

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick M. Abou‐Sleiman. A scholar is included among the top collaborators of Patrick M. Abou‐Sleiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick M. Abou‐Sleiman. Patrick M. Abou‐Sleiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gur, Ruben C., Jan Richard, Monica E. Calkins, et al.. (2012). Age group and sex differences in performance on a computerized neurocognitive battery in children age 8−21.. Neuropsychology. 26(2). 251–265. 377 indexed citations

Costa, Cristine Alvès da, Claire Sunyach, Emilie Giaime, et al.. (2009). Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nature Cell Biology. 11(11). 1370–1375. 168 indexed citations

Vandrovcová, Jana, Alan Pittman, Patrick M. Abou‐Sleiman, et al.. (2008). Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease. Neurobiology of Aging. 30(9). 1477–1482. 41 indexed citations

McKenzie, Matthew, Danae Liolitsa, Michelangelo Campanella, et al.. (2007). Mitochondrial ND5 Gene Variation Associated with Encephalomyopathy and Mitochondrial ATP Consumption. Journal of Biological Chemistry. 282(51). 36845–36852. 60 indexed citations

Abou‐Sleiman, Patrick M., Miratul M. K. Muqit, Neil Q. McDonald, et al.. (2006). A heterozygous effect for PINK1 mutations in Parkinson's disease?. Annals of Neurology. 60(4). 414–419. 131 indexed citations

Abou‐Sleiman, Patrick M., Michael G. Hanna, & Nicholas Wood. (2006). Genetic association studies of complex neurological diseases. Journal of Neurology Neurosurgery & Psychiatry. 77(12). 1302–1304. 21 indexed citations

Marques, Vanessa Daccach, Amilton Antunes Barreira, Mary B. Davis, et al.. (2006). Expanding the phenotypes of the Pro56SerVAPBmutation: Proximal SMA with dysautonomia. Muscle & Nerve. 34(6). 731–739. 61 indexed citations

Healy, Daniel G., Patrick M. Abou‐Sleiman, Juan P. Casas, et al.. (2006). UCHL‐1 is not a Parkinson's disease susceptibility gene. Annals of Neurology. 59(4). 627–633. 82 indexed citations

Pittman, Alan, A. J. W. Myers, Patrick M. Abou‐Sleiman, et al.. (2005). Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. Journal of Medical Genetics. 42(11). 837–846. 187 indexed citations

10.

Abou‐Sleiman, Patrick M., Daniel G. Healy, & Nicholas Wood. (2004). Causes of Parkinson?s disease: genetics of DJ-1. Cell and Tissue Research. 318(1). 185–188. 45 indexed citations

11.

Healy, Daniel G., Patrick M. Abou‐Sleiman, Tetsutaro Ozawa, et al.. (2004). A functional polymorphism regulating dopamine β‐hydroxylase influences against Parkinson's disease. Annals of Neurology. 55(3). 443–446. 40 indexed citations

12.

Healy, Daniel G., Patrick M. Abou‐Sleiman, & Nicholas Wood. (2004). PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism. The Lancet Neurology. 3(11). 652–662. 38 indexed citations

13.

Healy, Daniel G., Patrick M. Abou‐Sleiman, David B. Goldstein, & Nicholas Wood. (2004). Population genetics for target identification. Drug Discovery Today Technologies. 1(1). 69–74. 9 indexed citations

14.

Healy, Daniel G., Patrick M. Abou‐Sleiman, & Nicholas Wood. (2004). Genetic causes of Parkinson?s disease: UCHL-1. Cell and Tissue Research. 318(1). 189–194. 40 indexed citations

15.

Healy, Daniel G., Patrick M. Abou‐Sleiman, Kourosh R. Ahmadi, et al.. (2004). The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism. Annals of Neurology. 56(3). 329–335. 32 indexed citations

16.

Abou‐Sleiman, Patrick M.. (2002). Pregnancy following preimplantation genetic diagnosis for Crouzon syndrome. Molecular Human Reproduction. 8(3). 304–309. 27 indexed citations

17.

Harper, Joyce, Dagan Wells, Wirawit Piyamongkol, et al.. (2002). Preimplantation genetic diagnosis for single gene disorders: experience with five single gene disorders. Prenatal Diagnosis. 22(6). 525–533. 42 indexed citations

18.

Patrikidou, Anna, J. H. Bennett, Patrick M. Abou‐Sleiman, Joy D.A. Delhanty, & Malcolm Harris. (2002). A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla. Oral Oncology. 38(4). 383–390. 8 indexed citations

19.

Abou‐Sleiman, Patrick M., Angela Apessos, Joyce Harper, et al.. (2002). First application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2). Prenatal Diagnosis. 22(6). 519–524. 21 indexed citations

20.

Apessos, Angela, Patrick M. Abou‐Sleiman, Joyce Harper, & Joy Delhanty. (2001). Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers. Prenatal Diagnosis. 21(6). 504–511. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact